NCT06383832View on ClinicalTrials.gov

Effect of Dapagliflozin on Body Weight in Overweight Women Consuming Different Proportions of Carbohydrate Diet.

PHASE4CompletedINTERVENTIONAL
Enrollment

36

Participants

Timeline

Start Date

October 28, 2021

Primary Completion Date

December 26, 2023

Study Completion Date

December 26, 2023

Conditions
OverweightCarbohydrateSodium-glucose Transporter 2 Inhibitors
Interventions
DRUG

Dapagliflozin

Dapagliflozin tablets oral 10mg/d qd, intervention for 12 weeks.

Trial Locations (2)

Unknown

Zhujiang Hospital of Southern Medical University, Guangzhou

Zhujiang Hospital, Guangzhou

All Listed Sponsors
lead

Sun Jia

OTHER

NCT06383832 - Effect of Dapagliflozin on Body Weight in Overweight Women Consuming Different Proportions of Carbohydrate Diet. | Biotech Hunter | Biotech Hunter